athenahealth (NASDAQ: ATHN) is one of 18 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it weigh in compared to its competitors? We will compare athenahealth to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

Profitability

This table compares athenahealth and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
athenahealth 2.80% 6.91% 3.80%
athenahealth Competitors -18.12% -11.70% -2.05%

Volatility & Risk

athenahealth has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Comparatively, athenahealth’s competitors have a beta of 1.33, meaning that their average stock price is 33% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for athenahealth and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
athenahealth 2 11 11 0 2.38
athenahealth Competitors 70 391 763 10 2.58

athenahealth presently has a consensus target price of $148.77, suggesting a potential upside of 19.96%. As a group, “Medical Software & Technology Services” companies have a potential upside of 18.00%. Given athenahealth’s higher possible upside, equities research analysts clearly believe athenahealth is more favorable than its competitors.

Earnings and Valuation

This table compares athenahealth and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
athenahealth $1.15 billion $127.70 million 155.03
athenahealth Competitors $376.98 million $34.79 million 8.34

athenahealth has higher revenue and earnings than its competitors. athenahealth is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

63.1% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 3.2% of athenahealth shares are owned by company insiders. Comparatively, 24.4% of shares of all “Medical Software & Technology Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

athenahealth beats its competitors on 8 of the 13 factors compared.

About athenahealth

athenahealth, Inc. provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet. The Company has a range of network-enabled services to support healthcare providers across the continuum of care. The Company offers various combinations of its services to its clients, including athenaOne and athenaOne for Hospitals and Health Systems, depending on whether they are medical groups and practices or hospitals and larger health systems. As of December 31, 2016, the Company connected care across a national network of approximately 88,000 providers and approximately 86 million patients. Its suite of network-enabled services includes athenaCollector, athenaClinicals, athenaCommunicator, athenaCoordinator, Population Health and Epocrates.

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.